IGM Biosciences Inc
NASDAQ:IGMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IGM Biosciences Inc
NASDAQ:IGMS
|
US |
|
Dilip Buildcon Ltd
NSE:DBL
|
IN |
|
Yamagata Bank Ltd
TSE:8344
|
JP |
|
V-cube Inc
TSE:3681
|
JP |
|
Beijing North Star Co Ltd
SSE:601588
|
CN |
|
Purifloh Ltd
ASX:PO3
|
AU |
|
S
|
Sababa Security SpA
MIL:SBB
|
IT |
|
S
|
SPAR Group Ltd
JSE:SPP
|
ZA |
|
Aura Biosciences Inc
NASDAQ:AURA
|
US |
|
PTT Oil and Retail Business PCL
SET:OR
|
TH |
|
NAYA Biosciences Inc
NASDAQ:NAYA
|
US |
|
Travel + Leisure Co
NYSE:TNL
|
US |
|
Mathew Easow Research Securities Ltd
BSE:511688
|
IN |
|
P
|
Phoenix Group Holdings PLC
F:1BF
|
UK |
|
Sinovac Biotech Ltd
NASDAQ:SVA
|
CN |
|
G
|
GDEV Inc.
F:9T8
|
VG |
|
Japfa Ltd
SGX:UD2
|
SG |
|
Minmetals Development Co Ltd
SSE:600058
|
CN |
|
K
|
Kinx Inc
KOSDAQ:093320
|
KR |
Bankruptcy Probability
IGM Biosciences Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IGM Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
IGM Biosciences Inc
NASDAQ:IGMS
|
76.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IGM Biosciences Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IGM Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
